Physician profile
Rita Joyce
NPI 1437302577
$1,049.41
in general payments reported to CMS, 2019-2025
19 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.94 · 2022: $195 · 2023: $304 · 2024: $138 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $730 · Education: $92.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $730.36 |
| Education | $92.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $288.62 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $156.10 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $77.32 | 2023-2025 | Myfembree, Gemtesa |
| Novo Nordisk INC | $72.48 | 2023-2025 | Wegovy |
| Exact Sciences Corporation | $52.88 | 2025 | Cologuard Collection Kit |
| Organon LLC | $50.80 | 2022-2025 | Nexplanon |
| Pfizer INC. | $47.54 | 2021-2022 | |
| Lilly USA, LLC | $42.04 | 2025 | Zepbound |
| Millicent US INC | $36.12 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Exeltis, USA INC. | $35.63 | 2023-2024 | Slynd |
| Myovant Sciences INC. | $33.64 | 2022 | |
| Boston Scientific Corporation | $30.56 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $28.65 | 2023 | Seglentis |
| Provepharm INC. | $21.85 | 2025 | Bludigo |
| Mayne Pharma Commercial LLC | $18.66 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $15.33 | 2023 | Contrave |
| Bayer Healthcare Pharmaceuticals INC. | $15.21 | 2025 | |
| Mycovia Pharmaceuticals, INC. | $13.80 | 2022 | |
| Avion Pharmaceuticals | $12.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Joyce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.